J. Clayden et al. / Tetrahedron: Asymmetry 19 (2008) 2218–2221
2221
(2 mL) was added at ꢀ78 °C followed by water (5 mL) at rt. The
organic phase was washed with H3PO4 (0.5 M) then dried over
MgSO4 and concentrated under reduced pressure. The pure prod-
uct 8 was obtained after precipitation in Et2O/petrol followed by
flash chromatography on silica gel (95/5: DCM/AcOEt) (1.97 g,
77%). Mp: 122 °C. IR mmax cmꢀ1: 3317, 2959, 1644, 1503, 757,
736. 1H NMR (500 MHz, CDCl3) d (ppm): 1.27 (3H, dd, J = 6.9,
126 Hz), 1.27 (3H, dd, J = 5.3, 6.9 Hz), 1.35 (9H, s), 2.97 (1H, dsept,
J = 2.1, 6.9 Hz), 7.15 (1H, dt, J = 1.5, 7.5 Hz), 7.20 (1H, dt, J = 1.5,
7.5 Hz), 7.27 (1H, dd, J = 1.6, 7.5 Hz), 7.32 (1H, br s), 7.77 (1H, d,
J = 7.8 Hz). 13C NMR (75 MHz, CDCl3) d (ppm): 22.77, 27.68, 27.78
(1C, d, J = 109 Hz), 39.65, 124.24, 125.35, 125.56, 126.38, 134.36,
139.65, 176.58. MS (CI/NH3): 221 (MH+, 100). HRMS for
C1313CH22NO (MH+): calcd: 221.1729; found: 221.1726. Elem. Anal.
Calcd for C1313CH21NO: C, 76.32; H, 9.61; N, 6.36. Found: C, 76.67;
H, 9.84; N, 6.35.
added n-BuLi (1.0 cm3, 2.0 mmol, 2.0 M). The reaction mixture was
stirred for 30 min at –78 °C and then a solution of N-Boc-N-(p-
methoxyphenyl)-a-methylbenzylamine 14 (0.52 g, 1.6 mmol) in
toluene (1.6 cm3) was added. The resulting reaction mixture was
stirred at –78 °C for 9 h and then methyl iodide (0.12 cm3,
2.0 mmol) added. After stirring for 3 h at ꢀ78 °C, the reaction
was stirred at room temperature for 10 h. Water (10 cm3) was
added and extracted with EtOAc (3 ꢁ 10 cm3). The combined or-
ganic fractions were dried over MgSO4, filtered and concentrated
under reduced pressure. The residue was purified by flash column
chromatography (SiO2; petrol to 5% EtOAc in petrol) to give N-Boc-
N-(p-methoxyphenyl)-a,a-dimethylbenzylamine 15 (0.59 g, 86%),
as a colourless oil; Rf (20% EtOAc in petrol) 0.42; mmax (film)/cmꢀ1
2845 (OCH3) and 1699 (C@O); dH (500 MHz; CDCl3) 7.44 (2H, dd,
J = 8.0 and 1.0, CH-c), 7.27 (2H, dd, J = 8.0 and 7.5, CH-d), 7.19
(2H, d, J = 8.5, CH-a), 7.14 (1H, tt, J = 7.5 and 1.0, CH-e), 6.85 (2 H,
d, J = 8.5, CH-b), 3.75 [3 H, s, (ArOCH3)], 1.43 [6H, s, (CH3) ꢁ 2]
and 1.02 [9H, s, (CH3) ꢁ 3]; dC (75 MHz; CDCl3) 158.7 (C@O),
155.9 (C), 150.7 (C), 134.5 (C), 131.3 (CH), 128.3 (CH), 126.0 (CH),
124.7 (CH), 114.2 (CH), 80.2 (C), 61.6 (C), 55.7 (ArOCH3), 30.6
[(CH3) ꢁ 2] and 28.3 [(CH3) ꢁ 3]; m/z (ES+) 342 (100%, M+H+);
(found: M+H+, 342.2075, C21H28NO3 requires M+H, 342.2069).
4.7. (S)-2-(1-Methyl-2,2,2-trideuterioethyl)aniline 9
Pivanilide 7 (3.1 g, 13.9 mmol, 1 equiv) was dissolved in EtOH
(75 mL) and HClaq 10 M (30 mL). The reaction mixture was heated
at reflux for 72 h before NaOH 6 M (50 mL) was added. The aque-
ous phase was extracted with AcOEt and dried over MgSO4.
Acid–base washing provided 1.65 g of pure product 9 (85%). The
er was determined by derivatisation with phenylethylisocyanate
11 to be 87:13. IR mmax cmꢀ1: 3467, 3376, 2959, 1621, 1495, 749.
1H NMR (500 MHz, CDCl3) d (ppm): 1.27 (3H, d, J = 7.0 Hz), 2.89
(1H, q, 7.0 Hz), 3.65 (2H, br s), 6.69 (1H, dd, 1.0, 8.0 Hz), 6.79
(1H, t, J = 7.0 Hz), 7.03 (1H, t, J = 7.5 Hz), 7.15 (1H, d, J = 7.5 Hz).
13C NMR (75 MHz, CDCl3) d (ppm): 22.16, 27.38, 115.76, 118.97,
125.36, 126.48, 132.61, 143.27. MS (CI/NH3): 139 (MH+, 100).
HRMS for C9H11D3N (MH+): calcd: 139.1309; found: 139.1311.
Elem. Anal. Calcd for C9H10D3N: C, 78.20; H, 9.48; N, 10.13. Found:
C, 78.04; H, 9.89; N, 10.10.
Acknowledgments
We are grateful to the Leverhulme Trust, to the EPSRC and to
Pfizer Ltd for support of this project.
References
1. Foldamers; Hecht, S., Huc, I., Eds.; Wiley-VCH: Weinheim, 2007.
2. Hill, D. J.; Mio, M. J.; Prince, R. B.; Hughes, T. S.; Moore, J. S. Chem. Rev. 2001, 101,
3893.
3. Gellman, S. H. Acc. Chem. Res. 1998, 31, 173.
4. Huc, I. Eur. J. Org. Chem. 2004, 17.
5. Nakano, T.; Okamoto, Y. Chem. Rev. 2001, 101, 4013.
6. Cornelissen, J. H. L. M.; Rowan, A. E.; Nolte, R. J. M.; Sommerdijk, N. A. J. M.
Chem. Rev. 2001, 101, 4039.
4.8. (S)-2-(1-13C-Methylethyl)aniline 10
7. Clayden, J.; Lund, A.; Vallverdú, L.; Helliwell, M. Nature (London) 2004, 431, 966.
8. Clayden, J.; Vallverdú, L.; Helliwell, M. Chem. Commun. 2007, 2357.
9. Clayden, J.; Lemiègre, L.; Helliwell, M. J. Org. Chem. 2007, 72, 2302.
10. Clayden, J.; Lemiègre, L.; Morris, G. A.; Pickworth, M.; Snape, T. J.; Jones, L. H.
J. Am. Chem. Soc., in press.
11. Park, Y. S.; Boys, M. L.; Beak, P. J. Am. Chem. Soc. 1996, 118, 3757.
12. Faibish, N. C.; Park, Y. S.; Lee, S.; Beak, P. J. Am. Chem. Soc. 1997, 119, 11561.
13. Clayden, J.; Menet, C. J.; Mansfield, D. J. Chem. Commun. 2002, 38.
14. Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1969, 34, 2543.
15. Assignment of (R) stereochemistry to d-3 is based on previous assumptions
(see Refs. 11 and 12) that deuteration is retentive. We have reported examples
of related N-substituted benzyllithiums which deuterate with variable
stereospecificity (see Clayden, J.; Dufour, J.; Grainger, D.; Helliwell, M. J. Am.
Chem. Soc. 2007, 129, 7488). Previous reports (Refs. 11 and 12) did not quantify
the er of deuterated products.
16. Clayden, J. Organolithiums Selectivity for Synthesis; Pergamon: Oxford, 2002.
17. Court, J. J.; Hlasta, D. J. Tetrahedron Lett. 1996, 37, 1335.
18. Clayden, J.; Pink, J. H.; Westlund, N.; Wilson, F. X. Tetrahedron Lett. 1998, 39,
8377.
19. Clark, R. D.; Jahangir, A. Org. React. 1995, 47, 1.
20. Basu, A.; Beak, P. J. Am. Chem. Soc. 1996, 118, 1575.
21. Clayden, J.; Dufour, J. Tetrahedron Lett. 2006, 47, 6945; Clayden, J.; Turner, H.;
Pickworth, M.; Adler, T. Org. Lett. 2005, 7, 3147; Clayden, J.; Turner, H.;
Helliwell, M.; Moir, E. J. Org. Chem. 2008, 73, 4415.
The pivanilide 8 (1.8 g, 8.18 mmol, 1 equiv) was dissolved in
EtOH (25 mL) and HClaq 10 M (20 mL). The reaction mixture was
refluxed for 72 h before NaOH 6 M (50 mL) was added. The aque-
ous phase was extracted with AcOEt and dried over MgSO4.
Acid–base washing provided 750 mg of pure product 10 (68%).
The er was determined by derivatisation with phenylethylisocya-
nate 11 to be 91:9. IR mmax cmꢀ1: 3386, 2958, 1619, 1497, 748.
1H NMR (500 MHz, CDCl3) d (ppm): 1.27 (3H, dd, J = 6.8, 126 Hz),
1.27 (3H, dd, J = 5.4, 6.8 Hz), 2.92 (1H, dsept, J = 1.9, 6.8 Hz), 3.79
(2H, br s), 6.70 (1H, d, J = 7.9 Hz), 6.80 (1H, t, J = 7.5 Hz), 7.03 (1H,
dt, J = 1.4, 7.5 Hz), 7.16 (1H, dd, J = 1.3, 7.7 Hz). 13C NMR (75 MHz,
CDCl3) d (ppm): 22.27, 27.52 (1C, d, J = 109 Hz), 115.91, 119.15,
125.39, 126.50, 135.07, 143.01. MS (CI/NH3): 137 (MH+, 100).
HRMS for C813CH14N (MH+): calcd: 137.1154; found: 137.1158.
Elem. Anal. Calcd for C813CH13N: C, 79.37; H, 9.62; N, 10.28. Found:
C, 79.30; H, 9.92; N, 10.56.
22. Clayden, J.; Menet, C. J.; Mansfield, D. J. Org. Lett. 2000, 2, 4229.
23. Metallinos, C.; Nerdinger, S.; Snieckus, V. Org. Lett. 1999, 1, 1183.
24. Metallinos, C. Synlett 2002, 1556.
25. For recent developments, see Refs. 9 and 10.
26. Clayden, J.; Hennecke, U. Org. Lett. 2008, in press.
4.9. N-Boc-N-(p-methoxyphenyl)-a,a-dimethylbenzylamine, 15
The method reported by Beak11,12 was employed. To a solution
of TMEDA (0.30 cm3, 2.0 mmol) in toluene (2.0 cm3) at ꢀ78 °C was